CD274 and colorectal carcinoma: As conventional chemotherapeutics induce the expression of PD-L1 the novel combined therapeutic approaches in CRC have been introduced by focusing on targeting of PD-1/PD-L1 axis (Zou et al., 2016; Wang H. B. et al., 2017).